Skip to content
Research/Stress Adaptation/Trans-auricular Vagus Nerve Stimulation

Trans-auricular Vagus Nerve Stimulation

Trans-auricular vagus nerve stimulation (taVNS) is a non-invasive technique that targets the vagus nerve through the ear to modulate stress and enhance parasympathetic activity. It is thought to improve stress resilience and potentially support longevity by reducing chronic stress-related damage and promoting relaxation.

Intelligence Profile

Safety Profile

Safety Profile of Trans-Auricular Vagus Nerve Stimulation

Known Side Effects:
The current literature and clinical trials provide limited information about specific side effects associated with trans-auricular vagus nerve stimulation (taVNS). General side effects for vagus nerve stimulation can potentially include mild skin irritation at the stimulation site, dizziness, and headache. However, specific data regarding taVNS side effects are not detailed in the provided studies.

Contraindications:
Based on the general safety parameters for vagus nerve stimulation, contraindications might include individuals with cardiac pacemakers or other implanted electronic devices. There is no specific evidence from the provided literature addressing contraindications specific to taVNS.

Drug Interactions:
The evidence does not offer specific information about drug interactions with taVNS. As a conservative measure, caution may be advised when combining taVNS with medications that alter neurological or cardiac function.

Populations That Should Avoid It:
There is insufficient evidence in the current literature about specific populations that should avoid taVNS. However, care might be advised for individuals with skin conditions affecting the ear area or with the aforementioned contraindications. Special consideration should be given to populations such as pregnant women, children, and individuals with severe cardiac or neurological disorders, pending further research.

It is important to note that while some studies and clinical trials are ongoing, comprehensive safety data for taVNS is not yet robust. Further clinical studies are needed to clarify its safety profile fully.

Disclaimer:
This information is not personalized medical advice. For individual concerns, please consult a healthcare provider.

Free account required

Safety profile requires a free AXIFI account to access clinical data, safety profiles, and research papers.